BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3065665)

  • 21. Acinetobacter lwoffii peritonitis in a patient receiving continuous ambulatory peritoneal dialysis.
    Huddam B; Koçak G; Azak A; Duranay M
    Ther Apher Dial; 2013 Feb; 17(1):117-9. PubMed ID: 23379502
    [No Abstract]   [Full Text] [Related]  

  • 22. Initial treatment of CAPD peritonitis: poor response with association of cefazolin and amikacin.
    Onozato ML; Caramori JC; Barretti P
    Perit Dial Int; 1999; 19(1):88-9. PubMed ID: 10201353
    [No Abstract]   [Full Text] [Related]  

  • 23. Mycobacterium chelonae peritonitis associated with continuous ambulatory peritoneal dialysis.
    Merlin TL; Tzamaloukas AH
    Am J Clin Pathol; 1989 Jun; 91(6):717-20. PubMed ID: 2729184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rifampin use in peritoneal dialysis.
    Zimmerman SW; Johnson CA
    Perit Dial Int; 1989; 9(4):241-3. PubMed ID: 2488374
    [No Abstract]   [Full Text] [Related]  

  • 25. Vancomycin therapy for gram-positive peritonitis in patients on CAPD.
    Vargemezis V; Pasadakis P; Thodis H; Coucudis P; Peihaberis P; Jafer H; Jara F; Kartali S
    Adv Perit Dial; 1989; 5():128-9. PubMed ID: 2577394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urokinase for recurrent CAPD peritonitis.
    Pickering SJ; Bowley JA; Fleming SJ; Oppenheim BA; Ralston AJ; Sissons P; Ackrill P; Burnie J
    Lancet; 1987 May; 1(8544):1258-9. PubMed ID: 2884384
    [No Abstract]   [Full Text] [Related]  

  • 27. Tsukamurella peritonitis associated with continuous ambulatory peritoneal dialysis.
    Shaer AJ; Gadegbeku CA
    Clin Nephrol; 2001 Sep; 56(3):241-6. PubMed ID: 11597040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of peritonitis in CAPD with intraperitoneal rifampin.
    Paiva A; Cirugeda A; Bajo MA; Selgas R; Selgas R
    Perit Dial Int; 1998; 18(5):543-4. PubMed ID: 9848641
    [No Abstract]   [Full Text] [Related]  

  • 29. Group A streptococcal peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis.
    Cavalieri SJ; Allais JM; Schlievert PM; Dworzack DL; Clark RB
    Am J Med; 1989 Feb; 86(2):249-50. PubMed ID: 2643874
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
    Mounier M; Benevent D; Denis F
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imipenem/cilastatin sodium in the treatment of continuous ambulatory peritoneal dialysis-associated peritonitis.
    Lui SF; Cheng AB; Leung CB; Wong KC; Li PK; Lai KN
    Am J Nephrol; 1994; 14(3):182-6. PubMed ID: 7977477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Replacement of the peritoneal dialysis catheter in persistent peritonitis in continuous ambulatory peritoneal dialysis].
    Marichal JF; Faller B; Mengus C; Wagner JD; Frey G
    Nephrologie; 1985; 6(1):7-10. PubMed ID: 4000380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracatheter streptokinase for recurrent peritonitis in CAPD.
    Katirtzoglou AN; Apostolidis NS; Mountokalakis TD
    Clin Nephrol; 1991 Oct; 36(4):214. PubMed ID: 1959250
    [No Abstract]   [Full Text] [Related]  

  • 34. A novel agent of peritoneal dialysis-related peritonitis: Granulicatella adiacens.
    Altay M; Akay H; Yildiz E; Duranay M
    Perit Dial Int; 2008; 28(1):96-7. PubMed ID: 18178954
    [No Abstract]   [Full Text] [Related]  

  • 35. Newer quinolones in the treatment of continuous ambulatory peritoneal dialysis (CAPD) related infections.
    Nikolaidis P
    Perit Dial Int; 1990; 10(2):127-33. PubMed ID: 2085597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peritonitis associated with continuous ambulatory peritoneal dialysis: the pseudo-surgical abdomen.
    Apostolidis NS; Katirtzoglou AN; Manouras AJ; Moundokalakis TD
    Am Surg; 1993 Jul; 59(7):448-50. PubMed ID: 8323078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of intraperitoneal cefotaxime treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Petersen J; Stewart RD; Catto GR; Edward N
    Nephron; 1985; 40(1):79-82. PubMed ID: 4000338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relapsing peritonitis in continuous ambulatory peritoneal dialysis and an unconventional approach to treatment.
    Whaley-Connell A; Khanna R
    Adv Perit Dial; 2004; 20():71-3. PubMed ID: 15384799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Group A streptococcal peritonitis associated with continuous ambulatory peritoneal dialysis.
    Officer TP; Black J; Rotellar C; Winchester JF; Rakowski TA
    Am J Med; 1989 Oct; 87(4):487. PubMed ID: 2679078
    [No Abstract]   [Full Text] [Related]  

  • 40. Single-dose pefloxacin pharmacokinetics and metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nikolaidis P; Walker SE; Dombros N; Tourkantonis A; Paton TW; Oreopoulos DG
    Perit Dial Int; 1991; 11(1):59-63. PubMed ID: 2049424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.